Follow
Joakim Ramsberg
Joakim Ramsberg
The Swedish Brain Foundation and Karolinska Institutet
Verified email at hjarnfonden.se
Title
Cited by
Cited by
Year
Pharmaceutical regulation in 15 European countries
D Panteli, F Arickx, I Cleemput, G Dedet, H Eckhardt, E Fogarty, ...
Health systems in transition 18 (5), 1-118, 2016
1682016
The cost‐effectiveness of lifesaving interventions in Sweden
JAL Ramsberg, L Sjöberg
Risk Analysis 17 (4), 467-478, 1997
1181997
Nordic responses to Covid-19: Governance and policy measures in the early phases of the pandemic
IS Saunes, K Vrangbæk, H Byrkjeflot, SS Jervelund, HO Birk, ...
Health Policy 126 (5), 418-426, 2022
852022
Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model
J Ramsberg, C Asseburg, M Henriksson
Public Library of Science 7 (8), e42003, 2012
842012
Analyzing overall survival in randomized controlled trials with crossover and implications for economic evaluation
L Jönsson, R Sandin, M Ekman, J Ramsberg, C Charbonneau, X Huang, ...
Value in Health 17 (6), 707-713, 2014
792014
Patient evaluation of a novel non‐injectable anesthetic gel: a multicenter crossover study comparing the gel to infiltration anesthesia during scaling and root planing
D van Steenberghe, P Bercy, J De Boever, P Adriaens, L Geers, ...
Journal of periodontology 75 (11), 1471-1478, 2004
702004
A cost-effectiveness analysis of an in-hospital clinical pharmacist service
SM Wallerstedt, L Bladh, J Ramsberg
BMJ open 2 (1), e000329, 2012
442012
On survival consumption costs–a reply to Nyman
D Lundin, J Ramsberg
Health economics 17 (2), 293-297, 2008
302008
Data sharing and embedded research
GE Simon, G Coronado, LL DeBar, LM Dember, BB Green, SS Huang, ...
Annals of internal medicine 167 (9), 668-670, 2017
222017
Register or electronic health records enriched randomized pragmatic trials: The future of clinical effectiveness and cost-effectiveness trials?
J Ramsberg, M Neovius
Nordic Journal of Health Economics 5 (1), 62-76, 2017
212017
Opportunities and barriers for pragmatic embedded trials: triumphs and tribulations
J Ramsberg, R Platt
Learning Health Systems 2 (1), e10044, 2018
202018
Patient perspectives on centralisation of low volume, highly specialised procedures in Sweden
I Svederud, M Virhage, E Medin, J Grundström, S Friberg, J Ramsberg
Health Policy 119 (8), 1068-1075, 2015
192015
Examining the quality of health economic analyses submitted to the Pharmaceutical Benefits Board in Sweden: the first year
J Ramsberg, S Odeberg, A Engström, D Lundin
The European Journal of Health Economics 5, 351-356, 2004
162004
Importance of Cost and Effectiveness for Attitudes towards Lifesaving Interventions, The
J Ramsberg, L Sjoberg
Risk 9, 271, 1998
151998
Stuprörstänkande gör samhällets kostnader för ohälsa onödigt höga
J Ramsberg, M Ekelund
Ekonomisk debatt 39 (5), 41-53, 2011
132011
Dynamic cost-effectiveness: a more efficient reimbursement criterion
D Lundin, J Ramsberg
Forum for Health Economics & Policy 11 (2), 2008
132008
Challenges for sharing data from embedded research
R Platt, J Ramsberg
New England Journal of Medicine 374 (19), 1897-1897, 2016
112016
The cost-effectiveness of oral triptan therapy in Sweden
J Ramsberg, M Henriksson
Cephalalgia 27 (1), 54-62, 2007
112007
Comments on Bohnenblust and Slovic, and Vrijling, van Hengel and Houben
J Ramsberg
Reliability Engineering & System Safety 67 (2), 205-209, 2000
102000
The review of antidepressants
A Wessling, J Ramsberg
Dental and Pharmaceutical benefits Agtency, TLV, 2008
72008
The system can't perform the operation now. Try again later.
Articles 1–20